BMC Surgery · 2021 · 11 citations · 24 references
MedicineImmunologySurgeryGeneral SurgeryInflammationPerioperative Outcomes ResearchColorectal CancerGastrointestinal InflammationInflammatory Response RegulationRobot-assisted SurgerySurgical Stress Response ReductionSystemic Inflammatory ResponseColon Cancer SurgeryColonic InflammationInflammatory Response To SurgeryInflammatory Stress ResponsesLaparoscopic Cancer SurgeryPostoperative Systemic Inflammatory ResponseRobot-assisted Colorectal SurgerySystemic Inflammation Markers
BACKGROUND: Robot-assisted surgery is being increasingly adopted in treating colorectal cancer, and the transition from laparoscopic surgery to robot-assisted surgery is a trend. The evidence of the benefits of robot-assisted surgery is sparse. However, findings are associated with improved patient-related outcomes and overall morbidity rates compared to laparoscopic surgery. This induction is unclear, considering both surgical modalities are characterized as minimally invasive. This study aims to evaluate the systemic and peritoneal inflammatory stress response induced by robot-assisted surgery compared with laparoscopic surgery for elective colon cancer resections in a prospective, randomized controlled clinical trial. METHODS: This study is a single-centre randomized controlled superiority trial with 50 colon cancer participants. The primary endpoint is the level of systemic inflammatory response expressed as serum C-reactive protein (CRP) and interleukin 6 (IL-6) levels between postoperative days one and three. Secondary endpoints include (i) levels of systemic inflammation in serum expressed by a panel of inflammatory and pro-inflammatory cytokines measured during the first three postoperative days, (ii) postoperative surgical and medical complications (30 days) according to Clavien-Dindo classification and Comprehensive Complication Index, (iii) intraoperative blood loss, (iv) conversion rate to open surgery, (v) length of surgery, (vi) operative time, (vii) the number of harvested lymph nodes, and (viii) length of hospital stay. The exploratory endpoints are (i) levels of peritoneal inflammatory response in peritoneal fluid expressed by inflammatory and pro-inflammatory cytokines between postoperative day one and three, (ii) patient-reported health-related quality of recovery-15 (QoR-15), (iii) 30 days mortality rate, (iv) heart rate variability and (v) gene transcript (mRNA) analysis. DISCUSSION: To our knowledge, this is the first clinical randomized controlled trial to clarify the inflammatory stress response induced by robot-assisted or laparoscopic surgery for colon cancer resections. Trial registration This trial is registered at Clinicaltrials.gov (Identifier: NCT04687384) on December, 29, 2020, Regional committee on health research ethics, Region of Southern Denmark (N75709) and Data Protection Agency, Hospital Sønderjylland, University Hospital of Southern Denmark (N20/46179).
24
Classification of Surgical Complications
Daniel Dindo, Nicolas Demartines, Pierre-Alain Clavien · Annals of Surgery · 2004 · 30.9K citations · Full text
Medicine, Surgery, General Surgery +13
World Medical Association Declaration of Helsinki
JAMA · 2013 · 29.4K citations
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
A.-W. Chan, Jennifer Tetzlaff, Peter C Gøtzsche et al. · BMJ · 2013 · 7.1K citations · Full text
The Comprehensive Complication Index
Ksenija Slankamenac, Rolf Graf, Jeffrey Barkun et al. · Annals of Surgery · 2013 · 1.7K citations
Randomized clinical trial of robot-assisted <i>versus</i> standard laparoscopic right colectomy
J S Park, G-S Choi, S. Y. Park et al. · British journal of surgery · 2012 · 370 citations · Full text